Assets of Innate Pharma SA from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
ifrs-full: EUR
Summary
Innate Pharma SA quarterly Assets in EUR history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • Innate Pharma SA Assets for the quarter ending 31 Dec 2024 was €111,059,000, a 37% decline year-over-year.
Source SEC data
View on sec.gov
Assets, Quarterly (EUR)
Assets, YoY Quarterly Change (%)

Innate Pharma SA Quarterly Assets (EUR)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 €111,059,000 -€64,128,000 -37% 31 Dec 2024 20-F 30 Apr 2025 2024 FY
Q2 2024 €151,497,000 -€47,552,000 -24% 30 Jun 2024 6-K 12 Sep 2024 2024 Q2
Q4 2023 €175,187,000 -€24,108,000 -12% 31 Dec 2023 20-F 30 Apr 2025 2024 FY
Q2 2023 €199,049,000 -€81,381,000 -29% 30 Jun 2023 6-K 14 Sep 2023 2023 Q2
Q4 2022 €199,295,000 -€68,201,000 -25% 31 Dec 2022 20-F 30 Apr 2025 2024 FY
Q2 2022 €280,430,000 +€14,213,000 +5.3% 30 Jun 2022 6-K 15 Sep 2022 2022 Q2
Q4 2021 €267,496,000 -€39,927,000 -13% 31 Dec 2021 20-F 04 Apr 2024 2023 FY
Q2 2021 €266,217,000 30 Jun 2021 6-K 15 Sep 2021 2021 Q2
Q4 2020 €307,423,000 -€93,938,000 -23% 31 Dec 2020 20-F 06 Apr 2023 2022 FY
Q4 2019 €401,361,000 -€49,855,000 -11% 31 Dec 2019 20-F 04 Apr 2022 2021 FY
Q4 2018 €451,216,000 +€196,193,000 +77% 31 Dec 2018 20-F 27 Apr 2021 2020 FY
Q4 2017 €255,023,000 31 Dec 2017 20-F 24 Apr 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.